4.6 Article

Primary lateral sclerosis: consensus diagnostic criteria

Journal

JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
Volume 91, Issue 4, Pages 373-377

Publisher

BMJ PUBLISHING GROUP
DOI: 10.1136/jnnp-2019-322541

Keywords

-

Funding

  1. Motor Neurone Disease Association
  2. National Health and Medical Research Council of Australia [1132524, 1153439, 1156093]
  3. Italian Ministry of Health
  4. CDC
  5. Cytokinetics
  6. Biohaven
  7. Biogen
  8. MDA
  9. SPF
  10. Tsumura
  11. AriSLA (Fondazione Italiana di Ricerca per la SLA)
  12. National Health and Medical Research Council of Australia [1153439] Funding Source: NHMRC

Ask authors/readers for more resources

Primary lateral sclerosis (PLS) is a neurodegenerative disorder of the adult motor system. Characterised by a slowly progressive upper motor neuron syndrome, the diagnosis is clinical, after exclusion of structural, neurodegenerative and metabolic mimics. Differentiation of PLS from upper motor neuron-predominant forms of amyotrophic lateral sclerosis remains a significant challenge in the early symptomatic phase of both disorders, with ongoing debate as to whether they form a clinical and histopathological continuum. Current diagnostic criteria for PLS may be a barrier to therapeutic development, requiring long delays between symptom onset and formal diagnosis. While new technologies sensitive to both upper and lower motor neuron involvement may ultimately resolve controversies in the diagnosis of PLS, we present updated consensus diagnostic criteria with the aim of reducing diagnostic delay, optimising therapeutic trial design and catalysing the development of disease-modifying therapy.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available